American Joint Committee on Cancer (AJCC) The Future of Neuroendocrine Tumor Management

https://is1-ssl.mzstatic.com/image/thumb/Podcasts112/v4/08/77/ed/0877eda4-cbb1-bace-3644-e73fb7aced4f/mza_1512576652754283542.jpeg/600x600bb.jpg

NETCast

Podcasting4Associations

37 episodes

2 months ago

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Our episodes host leading neuroendocrine experts who will discuss the latest research, debate pros and cons of various treatment protocols, share information about establishing neuroendocrine centers, and much more.

Visit us at

All content for NETCast is the property of Podcasting4Associations and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

NETCast, brought to you by the North American Neuroendocrine Tumor Society (NANETS).

Visit us at

American Joint Committee on Cancer (AJCC) The Future of Neuroendocrine Tumor Management

NETCast

30 minutes 10 seconds

11 months ago

American Joint Committee on Cancer (AJCC) The Future of Neuroendocrine Tumor Management

In this episode, Dr. Aman Chauhan joins Dr. Renuka Iyer to discuss the critical updates in neuroendocrine tumors, focusing on the AJCC staging system and its implications for clinical practice. The conversation covers the evolution of staging systems, the role of biomarkers like chromogranin A, the importance of endoscopists in management, and the outcomes for appendiceal neuroendocrine tumors. The episode emphasizes the need for updated guidelines to improve patient care and outcomes in the field of oncology. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.